FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes September 20, 2023
KEYNOTE-087: Pembrolizumab Monotherapy for Relapsed/Refractory Classical Hodgkin lymphoma September 17, 2023
Expert Opinion: Children’s Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse August 24, 2023